title: Oral methotrexate for treatment of ectopic pregnancy.
abstract: OBJECTIVE
  The purpose of this study was to evaluate oral methotrexate tablets in the treatment of ectopic pregnancy.
  
  
  METHODS
  Patients with a diagnosis of ectopic pregnancy were offered oral methotrexate tablets rather that intramuscular injection. Oral methotrexate was given in 2 divided doses 2 hours apart at a dose of 60 mg/m(2) with standard 2.5 mg methotrexate tablets. Patients were followed up with the use of the same protocol that was used typically for intramuscular methotrexate.
  
  
  RESULTS
  Nineteen of 22 patients (86%) were successfully treated. There was no statistical difference between patients who were treated successfully or unsuccessfully, with respect to initial human chorionic gonadotropin titers (P =.55), ectopic size (P =.77), or methotrexate dose (P =.18). Nineteen of 22 patients (86%) had increased pain during treatment. Outside of pain, gastrointestinal side effects were the most common. Thirty-two percent of patients required more than one treatment cycle.
  
  
  CONCLUSIONS
  Oral methotrexate can be used to treat ectopic pregnancy successfully, but there are few advantages to recommend its use over intramuscular methotrexate.
authors.affiliation: Department of Obstetrics and Gynecology, University of Tennessee Health Science Center, Memphis, USA.
authors.forename: Gary H
authors.initials: GH
authors.lastname: Lipscomb
authors.forename: Norman L
authors.initials: NL
authors.lastname: Meyer
authors.forename: Darby E
authors.initials: DE
authors.lastname: Flynn
authors.forename: Matt
authors.initials: M
authors.lastname: Peterson
authors.forename: Frank W
authors.initials: FW
authors.lastname: Ling
mesh_terms: D000020:Abortifacient Agents, Nonsteroidal / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D000284:Administration, Oral; D000328:Adult; D006063:Chorionic Gonadotropin / Q000097:blood; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D010146:Pain / Q000139:chemically induced; D011247:Pregnancy; D011271:Pregnancy, Ectopic / Q000097:blood / Q000000981:diagnostic imaging / Q000188:drug therapy*; D019233:Retreatment; D016896:Treatment Outcome; D014463:Ultrasonography
chemical_list: D000020:Abortifacient Agents, Nonsteroidal; D006063:Chorionic Gonadotropin; D008727:Methotrexate